Antal Rohit Desai - Sep 26, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director, 10%+ Owner
Signature
/s/ Antal Rohit Desai
Stock symbol
RETA
Transactions as of
Sep 26, 2023
Transactions value $
$0
Form type
4
Date filed
9/28/2023, 04:32 PM
Previous filing
Jun 16, 2023
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Disposed to Issuer -31.5K -100% 0 Sep 26, 2023 By The 2:22 DNA Trust F1, F3, F4
transaction RETA Class A common stock Disposed to Issuer -113 -100% 0 Sep 26, 2023 By CPMG, Inc. F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -117K -100% 0 Sep 26, 2023 By Nighthawk Partners, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -282K -100% 0 Sep 26, 2023 By Willet Fund, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -138K -100% 0 Sep 26, 2023 By Killdeer Fund, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -5.46K -100% 0 Sep 26, 2023 By Elepaio Partners, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -44.2K -100% 0 Sep 26, 2023 By Barred Owl Partners, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -34.9K -100% 0 Sep 26, 2023 By Managed Account for Trustees of the University of Pennsylvania F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -443K -100% 0 Sep 26, 2023 By Gallopavo, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -748K -100% 0 Sep 26, 2023 By Roadrunner Fund, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -431K -100% 0 Sep 26, 2023 By Yellow Warbler, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -109K -100% 0 Sep 26, 2023 By Mallard Fund, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -37.9K -100% 0 Sep 26, 2023 By Crested Crane, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -335K -100% 0 Sep 26, 2023 By Sandpiper Fund, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -160K -100% 0 Sep 26, 2023 By Kestrel Fund, LP( F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -11.1K -100% 0 Sep 26, 2023 By CD Fund, LP F2, F3, F4
transaction RETA Class A common stock Disposed to Issuer -134 -100% 0 Sep 26, 2023 By Redbird Life Sciences Partners, LP F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Class B common stock Disposed to Issuer -1.25K -100% 0 Sep 26, 2023 Class A common stock 1.25K By CPMG, Inc. F2, F3, F4, F5
transaction RETA Class B common stock Disposed to Issuer -150K -100% 0 Sep 26, 2023 Class A common stock 150K By Mallard Fund, LP F2, F3, F4, F5
transaction RETA Class B common stock Disposed to Issuer -308K -100% 0 Sep 26, 2023 Class A common stock 308K By Kestrel Fund, LP F2, F3, F4, F5
transaction RETA Class B common stock Disposed to Issuer -123K -100% 0 Sep 26, 2023 Class A common stock 123K By CD Fund, LP F2, F3, F4, F5
transaction RETA Class B common stock Disposed to Issuer -1.49K -100% 0 Sep 26, 2023 Class A common stock 1.49K By Redbird Life Sciences Partners, LP F2, F3, F4, F5
transaction RETA Class B common stock Disposed to Issuer -115K -100% 0 Sep 26, 2023 Class A common stock 115K By Willet Fund, LP F2, F3, F4, F5
transaction RETA Class B common stock Disposed to Issuer -994K -100% 0 Sep 26, 2023 Class A common stock 994K By Yellow Warbler, LP F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Antal Rohit Desai is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust.
F2 CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the "Funds"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4.
F3 Each of CPMG, Inc. and Mr. Desai (collectively, the "Reporting Persons") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
F4 Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. ("Biogen") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the "Effective Time"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes.
F5 The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date.

Remarks:

Mr. McGaughy, Jr. serves on the Issuer's Board of Directors (the "Board") as a representative of CPMG, Inc. By virtue of his representation on the Board, for purposes of Section 16 of the Exchange Act, the Reporting Persons may be deemed to be directors of the Issuer by deputization of Mr. McGaughy, Jr.